Stock Code: Tianshui Zhongxing Bio-Technology Co.Ltd(002772) stock abbreviation: Tianshui Zhongxing Bio-Technology Co.Ltd(002772) Announcement No.: 2022025
Bond Code: 128026 bond abbreviation: Zhongxing convertible bond
Tianshui Zhongxing Bio-Technology Co.Ltd(002772)
Announcement on applying for comprehensive credit line from banks and other financial institutions in 2022
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Tianshui Zhongxing Bio-Technology Co.Ltd(002772) (hereinafter referred to as “the company”) held the 12th meeting of the 4th board of directors on March 23, 2022, deliberated and adopted the proposal on applying for comprehensive credit line from banks and other financial institutions in 2022. In order to meet the needs of the company’s production, operation and business development, broaden investment and financing channels, and combined with the actual situation of the company, the company (including subsidiaries within the scope of consolidated statements) plans to apply to China Industrial And Commercial Bank Of China Limited(601398) The nation’s acomprehensive credit line of RMB, The validity period shall be within 12 months after the deliberation and approval of the general meeting of shareholders, and the amount can be recycled within the validity period.
This comprehensive credit line includes but is not limited to working capital loan, non working capital loan, acceptance bill, factoring, letter of guarantee, opening letter of credit and bill discount. The comprehensive credit line is not equal to the actual financing amount of the company. The specific cooperative financial institution, final financing amount and financing form will be further negotiated with relevant institutions in the future, and the officially signed agreement or contract shall prevail. When applying for credit line or financing, the company and its subsidiaries can mortgage their own houses, buildings, land use rights, equipment and other assets. At the same time, the board of directors of the company requests the general meeting of shareholders to authorize the operation and management of the company to fully handle the above financing matters according to the actual business needs, including but not limited to the selection of financing institutions, the determination of financing amount and interest rate, the signing of financing application, guarantee and other contract documents.
The proposal to apply for comprehensive credit line from banks and other financial institutions needs to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation.
It is hereby announced
Tianshui Zhongxing Bio-Technology Co.Ltd(002772) board of directors March 23, 2022
